DAKGESUNDHEIT
A United Kingdom buyer, with 25 published contracts, worth £102.3m, most recently 4 months ago.
Top 5 suppliers won 100% of awarded value — £62.8m of £62.8m across 10 awards.
The German Social Code allows health insurance funds and pharmaceutical companies to enter into framework discount agreements for medications covered by statutory health insurance. In accordance with the relevant legal provisions for public procurement, a regular process of substance-related formal
The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the drug Cyanocobalamin (ATC B03BA01) under the provisions of § 130a Abs. 8 SGB V. This agreement will be effective from July 1, 2025, to June 30, 2027, with an option to extend for an additional 12 months.
The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the pharmaceutical substances Dolutegravir and Rilpivirine, classified under ATC J05AR21. This agreement will be effective from July 1, 2025, to June 30, 2027. The contract is part of a framework that allows
